Galen eCalcs - Calculator: Tufts DPP Risk Estimator
Revision as of 19:34, 20 November 2019 by David.Burkhead (talk | contribs)
Description
This is a calculator designed to accompany a research study driven by Tufts University that is investigating the relative risk reduction of adopting a DPP lifestyle on type 2 diabetes onset.
Limitations
This calculator was not designed for client-wide utilization and is not recommended to use this calculator unless the organization is part of the study.
Ranges
Target patients are prediabetic patients aged 25-75.
Calculator Inputs
Input | Mapping Type | Description |
---|---|---|
A1C | Results | Patient’s A1C value |
Blood Glucose | Results | Patient’s blood/plasma glucose value |
BMI | Vital Signs | Patient’s BMI |
Current Smoker | Problems | Patient is a current smoker |
Fasting Blood Glucose | Results | Patient's fasting blood/plasma glucose level |
Fasting Other | Results | Any fasting lab other than a fasting blood/plasma glucose |
Former Smoker | Problems | Patient is a former smoker |
HDL Cholesterol | Results | Patient’s HDL cholesterol value |
Height | Vital Signs | Patient’s height |
Hypertension | Problems | Patient’s hypertension problem status |
Non-smoker | Problems | Patient has never been a smoker |
Systolic Blood Pressure | Vital Signs | Patient’s systolic blood pressure |
Triglycerides | Results | Patient’s triglyceride value |
Weight | Vital Signs | Patient’s weight |
Calculator Outputs
Output | Mapping Type | Description |
---|---|---|
DPP NNT | Result | The average number of patients who need to be adopting the DDP lifestyle treatment to prevent one additional case of developing type 2 diabetes in the next 3 years |
DPP Risk | Result | Risk of developing type 2 diabetes in the next 3 years with the |
Interpretation | Result | Interpretation of calculator’s results |
Metformin NNT | Result | The average number of patients who need to be treated with Metformin to prevent one additional case of developing type 2 diabetes in the next 3 years |
Metformin Risk | Result | The risk of developing type 2 diabetes in the next 3 years with Metformin treatment |
Usual Care Risk | Result | Risk of developing type 2 diabetes in the next 3 years with the usual care treatment |